Market Closed -
Nasdaq Stockholm
10:32:17 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
209
SEK
|
+1.95%
|
|
+0.97%
|
+2.96%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,529
|
4,808
|
4,529
|
2,324
|
2,313
|
2,381
|
-
|
-
|
Enterprise Value (EV)
1 |
2,337
|
4,637
|
4,293
|
2,001
|
1,983
|
2,026
|
1,984
|
1,938
|
P/E ratio
|
29.4
x
|
51.8
x
|
54.5
x
|
57.1
x
|
137
x
|
156
x
|
74.9
x
|
53.3
x
|
Yield
|
0.45%
|
0.26%
|
0.33%
|
0.64%
|
0.64%
|
0.72%
|
0.93%
|
1.21%
|
Capitalization / Revenue
|
4.04
x
|
6.7
x
|
6.88
x
|
3.76
x
|
3.68
x
|
3.64
x
|
3.41
x
|
3.21
x
|
EV / Revenue
|
3.73
x
|
6.47
x
|
6.52
x
|
3.24
x
|
3.16
x
|
3.1
x
|
2.84
x
|
2.62
x
|
EV / EBITDA
|
12.7
x
|
23.6
x
|
23.5
x
|
13.5
x
|
18.4
x
|
18.1
x
|
14.5
x
|
12.6
x
|
EV / FCF
|
16.9
x
|
46.4
x
|
77
x
|
21.9
x
|
37.9
x
|
38.2
x
|
27.6
x
|
23.6
x
|
FCF Yield
|
5.92%
|
2.16%
|
1.3%
|
4.57%
|
2.64%
|
2.62%
|
3.63%
|
4.23%
|
Price to Book
|
2.2
x
|
4.31
x
|
3.58
x
|
1.65
x
|
1.69
x
|
1.67
x
|
1.65
x
|
1.63
x
|
Nbr of stocks (in thousands)
|
11,394
|
11,394
|
11,394
|
11,394
|
11,394
|
11,394
|
-
|
-
|
Reference price
2 |
222.0
|
422.0
|
397.5
|
204.0
|
203.0
|
209.0
|
209.0
|
209.0
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/2/22
|
1/27/23
|
1/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
626
|
717.2
|
658.2
|
618.3
|
627.7
|
654
|
699
|
741
|
EBITDA
1 |
183.4
|
196.5
|
182.5
|
148.3
|
107.5
|
112.2
|
137
|
154
|
EBIT
1 |
111.5
|
123.7
|
109.2
|
62.57
|
11.32
|
16
|
41
|
57
|
Operating Margin
|
17.82%
|
17.25%
|
16.6%
|
10.12%
|
1.8%
|
2.45%
|
5.87%
|
7.69%
|
Earnings before Tax (EBT)
1 |
109.5
|
120.1
|
107.4
|
51.97
|
17.38
|
19.7
|
41
|
58
|
Net income
1 |
85.89
|
92.69
|
83.14
|
40.62
|
16.82
|
15.2
|
32
|
45
|
Net margin
|
13.72%
|
12.92%
|
12.63%
|
6.57%
|
2.68%
|
2.32%
|
4.58%
|
6.07%
|
EPS
2 |
7.540
|
8.140
|
7.300
|
3.570
|
1.480
|
1.340
|
2.790
|
3.920
|
Free Cash Flow
1 |
138.5
|
99.99
|
55.74
|
91.5
|
52.39
|
53
|
72
|
82
|
FCF margin
|
22.12%
|
13.94%
|
8.47%
|
14.8%
|
8.35%
|
8.1%
|
10.3%
|
11.07%
|
FCF Conversion (EBITDA)
|
75.5%
|
50.89%
|
30.54%
|
61.72%
|
48.73%
|
47.24%
|
52.55%
|
53.25%
|
FCF Conversion (Net income)
|
161.21%
|
107.88%
|
67.04%
|
225.26%
|
311.48%
|
348.68%
|
225%
|
182.22%
|
Dividend per Share
2 |
1.000
|
1.100
|
1.300
|
1.300
|
1.300
|
1.500
|
1.940
|
2.530
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/2/22
|
1/27/23
|
1/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
170
|
154.7
|
174.5
|
145.1
|
144
|
-
|
156
|
156.1
|
151.7
|
173
|
162.2
|
167.2
|
EBITDA
1 |
54.07
|
38.28
|
45.89
|
36.32
|
27.76
|
-
|
28.17
|
19.1
|
22.01
|
27.6
|
33.8
|
28.8
|
EBIT
1 |
34.09
|
18.49
|
25.24
|
14.46
|
4.383
|
-
|
3.989
|
-5.287
|
-2.043
|
3.5
|
9.8
|
4.7
|
Operating Margin
|
20.05%
|
11.95%
|
14.46%
|
9.97%
|
3.04%
|
-
|
2.56%
|
-3.39%
|
-1.35%
|
2.02%
|
6.04%
|
2.81%
|
Earnings before Tax (EBT)
1 |
33.41
|
17.63
|
25.61
|
15.35
|
-6.612
|
-
|
6.096
|
-4.17
|
1.828
|
3.5
|
9.7
|
4.6
|
Net income
1 |
26.27
|
14.02
|
19.97
|
12.36
|
-5.733
|
-6.26
|
6.395
|
-2.59
|
1.853
|
2.6
|
7.3
|
3.5
|
Net margin
|
15.45%
|
9.06%
|
11.44%
|
8.52%
|
-3.98%
|
-
|
4.1%
|
-1.66%
|
1.22%
|
1.5%
|
4.5%
|
2.09%
|
EPS
|
2.310
|
1.230
|
1.750
|
1.090
|
-0.5000
|
-0.5500
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/2/22
|
4/26/22
|
7/15/22
|
10/21/22
|
1/27/23
|
7/18/23
|
10/24/23
|
1/26/24
|
4/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
192
|
171
|
236
|
324
|
330
|
355
|
397
|
443
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
138
|
100
|
55.7
|
91.5
|
52.4
|
53
|
72
|
82
|
ROE (net income / shareholders' equity)
|
7.88%
|
8.18%
|
6.98%
|
3.04%
|
1.21%
|
1.1%
|
2.2%
|
3.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
101.0
|
97.90
|
111.0
|
124.0
|
120.0
|
125.0
|
126.0
|
128.0
|
Cash Flow per Share
|
15.20
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
35.1
|
43.4
|
-
|
52.4
|
33.2
|
25
|
27
|
30
|
Capex / Sales
|
5.61%
|
6.05%
|
-
|
8.48%
|
5.28%
|
3.82%
|
3.86%
|
4.05%
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/2/22
|
1/27/23
|
1/26/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +2.96% | 217M | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|